MedPath

Physiologic Signals and Signatures With the Accuryn Monitoring System (The Accuryn Registry)

Completed
Conditions
Intraabdominal Hypertension
Cardiovascular Surgery
Abdominal Compartment Syndrome
Acute Kidney Injury
Interventions
Device: Accuryn Monitoring System
Registration Number
NCT04585555
Lead Sponsor
Potrero Medical
Brief Summary

The Accuryn Registry Study is an open-ended, global, multi-center, retrospective and prospective, single-arm data collection study with an FDA cleared device. The target population are cardiovascular surgery patients. Physiologic data measurements will be collected from enrolled subjects using electronic medical records and data streams via the Accuryn Monitoring System.

Detailed Description

The primary objective of the Accuryn Registry Study is to is to track and analyze changes in physiologic data streams using the Accuryn Monitoring System and correlate these changes to the occurrence of acute kidney injury (AKI) following cardiovascular surgery intervention(s).

The secondary objective is to determine the incidence of IAH and ACS in the cardiovascular surgery population and the correlation of these diagnoses to the diagnosis of AKI.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
50
Inclusion Criteria
  1. Adult (age ≥ 18).
  2. Monitored on the Accuryn® Monitoring System during hospital stay.
  3. Patient is undergoing cardiovascular surgical intervention(s).
Exclusion Criteria
  1. The patient is unsuitable for the study, in the opinion of the investigator. This may include vulnerable patient populations such as prisoners or those detained in a penal institution.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Accuryn Monitoring SystemAccuryn Monitoring SystemObservational only (no intervention). Patients undergoing cardiovascular surgical intervention(s) monitored with the Accuryn Monitoring System (per standard of care) during their hospital stay.
Primary Outcome Measures
NameTimeMethod
Intra-Abdominal Pressure (IAP)30 days

Intra-Abdominal Pressure (mmHg) trending while on a urinary catheter, as well as active measurements taken by clinician

Temperature (T)30 days

Temperature (degrees Celsius) trending during hospital stay

Abdominal Compartment Syndrome (ACS)30 days

Intra-abdominal pressure (IAP) above 20 mm Hg with new organ dysfunction or failure (timepoint and duration)

Urine Output (UO)30 days

High accuracy Urine Output (mL/hour) while on a urinary catheter, and estimated UO while not on a urinary catheter

Intraabdominal Hypertension (IAH)30 days

Intra-abdominal pressure (IAP) above 12 mm Hg (timepoint and duration)

Acute Kidney Injury (AKI)30 days

% of patients diagnosed with AKI, and hospitalization day of diagnosis. AKI diagnosed per KDIGO criteria (Stage 1 to 3)

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Emory University Hospital

🇺🇸

Atlanta, Georgia, United States

© Copyright 2025. All Rights Reserved by MedPath